Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Contract Type
partnership
BostonInformation TechnologyBiotechnologyDescription
Labviva has announced the close of its $25 million Series B funding, bringing its total funding to $55 million. The investment, led by 53 Stations, Biospring Partners, B Capital Group, and Glasswing Ventures, will be used to accelerate new product development, bolster marketing and customer support, and expand internationally. The partnership with 53 Station’s Co-Founder and Managing Partner, Jason Pritzker, reflects Labviva’s booming growth and escalating demand in Biopharma for automated supply chain and procurement solutions.